Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-08-001736
Filing Date
2008-09-02
Accepted
2008-09-02 17:28:47
Documents
4
Group Members
WORKING OPPORTUNITY FUND (EVCC) LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13-D sch13d_16083.htm SC 13D 145090
2 AGREEMENT exh-701_16083.htm EX-99.7.01 5869
3 ARRANGEMENT AGREEMENT exh-702_16083.htm EX-99.7.02 1311579
4 ESCROW AGREEMENT exh-703_16083.htm EX-99.7.03 188081
  Complete submission text file 0001072613-08-001736.txt   1652945
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45969 | Film No.: 081052190
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5
Business Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5 604-895-7255
GrowthWorks Capital Ltd. (Filed by) CIK: 0001444153 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D